Page last updated: 2024-08-26

bosentan anhydrous and Obesity

bosentan anhydrous has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoepf, TM; Holycross, BJ; McCune, SA; Radin, MJ1
Bang, WD; Chang, HJ; Cho, SS; Jang, JY; Joung, B; Kim, JY; Oh, CM; Yu, HT1

Other Studies

2 other study(ies) available for bosentan anhydrous and Obesity

ArticleYear
Salt-induced cardiac hypertrophy is independent of blood pressure and endothelin in obese, heart failure-prone SHHF rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2008, Volume: 30, Issue:7

    Topics: Animals; Base Sequence; Blood Pressure; Bosentan; Cardiomegaly; DNA Primers; Endothelin Receptor Antagonists; Endothelins; Gene Expression; Heart Failure; Leptin; Male; Nitric Oxide Synthase; Obesity; Rats; RNA, Messenger; Sodium Chloride, Dietary; Sulfonamides

2008
Pulmonary hypertension associated with use of phentermine.
    Yonsei medical journal, 2010, Volume: 51, Issue:6

    Topics: Adult; Antihypertensive Agents; Bosentan; Electrocardiography; Female; Humans; Hypertension, Pulmonary; Models, Chemical; Obesity; Phentermine; Radiography, Thoracic; Safety; Sulfonamides

2010